hemispherx biopharma inc
(HEB:Consolidated issues listed on NYSE MKT LLC)
Robert Dickey IV
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 6 different industries.|
Mr. Robert Dickey, IV, also known as Rob, has been Chief Financial Officer and Vice President of Finance at Tyme Technologies, Inc. since May 15, 2015. Mr. Dickey serves as Managing Director of DSS Partners LLC. He served as the Chief Financial Officer of Caladrius Biosciences, Inc. (formerly Neostem, Inc.) from August 19, 2013 to January 15, 2015. He served as a Senior Vice President of Hemispherx Biopharma, Inc. from June 2009 to August 16, 2013. He served as Vice ...
One Penn CenterPhone: 215-988-0080
Philadelphia, Pennsylvania 19103
Board Members Memberships*There is no Board Members Memberships data available.
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|